IDEAYA Biosciences (IDYA) News Today $20.05 +0.49 (+2.51%) Closing price 04:00 PM EasternExtended Trading$20.10 +0.05 (+0.24%) As of 05:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IDYA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Position Increased by Voloridge Investment Management LLCVoloridge Investment Management LLC raised its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 50.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 286,759 shares of the compaMay 27 at 4:39 AM | marketbeat.comSquarepoint Ops LLC Buys 33,088 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Squarepoint Ops LLC raised its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 22.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 178,892 shares of the companyMay 27 at 4:31 AM | marketbeat.comIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives $54.27 Average Target Price from BrokeragesMay 27 at 3:49 AM | americanbankingnews.comIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Sold by Two Sigma Investments LPTwo Sigma Investments LP decreased its position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 15.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 423,774 shares of the company's stock afterMay 26 at 4:25 AM | marketbeat.comNeo Ivy Capital Management Makes New Investment in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Neo Ivy Capital Management acquired a new stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 130,806 shares of the company's stock, valued at approxMay 25, 2025 | marketbeat.comIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the fourteen research firms that are presently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating, eleven haveMay 24, 2025 | marketbeat.comJPMorgan Chase & Co. Issues Positive Forecast for IDEAYA Biosciences (NASDAQ:IDYA) Stock PriceJPMorgan Chase & Co. lifted their target price on IDEAYA Biosciences from $63.00 to $66.00 and gave the company an "overweight" rating in a research report on Thursday.May 24, 2025 | marketbeat.comTwinbeech Capital LP Sells 71,664 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Twinbeech Capital LP lowered its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 44.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 87,802 shares of the company's stock after selling 71,664 shMay 24, 2025 | marketbeat.comBank of America Corp DE Acquires 41,390 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Bank of America Corp DE lifted its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 5.9% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 747,934 shares of the company's stock after purchasing an additional 41,390 shares during the period. BankMay 22, 2025 | marketbeat.comJane Street Group LLC Reduces Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Jane Street Group LLC trimmed its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 30.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 54,934 shares of the company's stock afteMay 22, 2025 | marketbeat.comTema Etfs LLC Purchases New Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Tema Etfs LLC purchased a new stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 16,066 shares of the company's stock, valuedMay 21, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Lowers Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)D. E. Shaw & Co. Inc. decreased its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 68.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 180,676 shares of the company's stock after selling 387,055 shares during the period. D.May 20, 2025 | marketbeat.comPolar Capital Holdings Plc Sells 589,500 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Polar Capital Holdings Plc lowered its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 90.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 65,500 shares of the company's stock after selling 589,500 sharMay 19, 2025 | marketbeat.comDeutsche Bank AG Grows Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Deutsche Bank AG lifted its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 6.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 372,979 shares of the company's stock after purchasingMay 19, 2025 | marketbeat.comJanuary 2026 Options Now Available For IDEAYA BiosciencesMay 17, 2025 | nasdaq.comMPM Bioimpact LLC Buys Shares of 414,035 IDEAYA Biosciences, Inc. (NASDAQ:IDYA)MPM Bioimpact LLC bought a new stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 414,035 shares of the company's stock, valued at approximately $10,641,May 16, 2025 | marketbeat.comJanus Henderson Group PLC Acquires 695,263 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Janus Henderson Group PLC increased its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 13.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,857,639 shares of the company's stock after acquiMay 15, 2025 | marketbeat.comEnsign Peak Advisors Inc Cuts Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Ensign Peak Advisors Inc reduced its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 7.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 564,217 shares of the company's stock after selling 47,597 shares during the periMay 14, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Sells 15,785 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)The Manufacturers Life Insurance Company lessened its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 16.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 82,602 shares of theMay 13, 2025 | marketbeat.comFY2025 EPS Estimates for IDYA Cut by Cantor FitzgeraldIDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) - Investment analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for IDEAYA Biosciences in a report issued on Thursday, May 8th. Cantor Fitzgerald analyst L. Watsek now expects that the company will post earnings of ($2.62) per shMay 13, 2025 | marketbeat.comDimensional Fund Advisors LP Has $8.91 Million Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Dimensional Fund Advisors LP lowered its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 7.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 346,765 shares of the company's stock after selling 2May 12, 2025 | marketbeat.com16,769 Shares in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Acquired by Raymond James Financial Inc.Raymond James Financial Inc. acquired a new stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 16,769 shares of the company's stock, valued at approximaMay 12, 2025 | marketbeat.comLeerink Partnrs Has Positive Outlook of IDYA Q2 EarningsIDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) - Analysts at Leerink Partnrs increased their Q2 2025 earnings per share (EPS) estimates for shares of IDEAYA Biosciences in a research note issued to investors on Tuesday, May 6th. Leerink Partnrs analyst A. Berens now expects that the companyMay 11, 2025 | marketbeat.comBrokers Offer Predictions for IDYA Q2 EarningsIDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) - Wedbush issued their Q2 2025 earnings per share (EPS) estimates for IDEAYA Biosciences in a note issued to investors on Tuesday, May 6th. Wedbush analyst R. Driscoll expects that the company will post earnings of ($0.88) per share for the quaMay 11, 2025 | marketbeat.comA Look At The Fair Value Of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)May 10, 2025 | finance.yahoo.comDAFNA Capital Management LLC Purchases 27,417 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)DAFNA Capital Management LLC grew its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 5.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 498,827 shares of the company's stock after purchasing an additional 27,417 sharMay 10, 2025 | marketbeat.comIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Purchased by Deerfield Management Company L.P. Series CDeerfield Management Company L.P. Series C grew its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 5.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,736,000 shares of the company's stockMay 10, 2025 | marketbeat.comCrestline Management LP Buys 70,571 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Crestline Management LP raised its position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 283.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 95,428 shares of the company's stock after acquiring an additiMay 10, 2025 | marketbeat.comBrevan Howard Capital Management LP Increases Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Brevan Howard Capital Management LP increased its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 210.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,539 shMay 10, 2025 | marketbeat.comAxa S.A. Grows Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Axa S.A. grew its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 20.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 249,702 shares of the company's stock after buying an additional 41May 9, 2025 | marketbeat.comIDEAYA Biosciences (NASDAQ:IDYA) Announces Earnings ResultsIDEAYA Biosciences (NASDAQ:IDYA - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.82) earnings per share for the quarter, missing the consensus estimate of ($0.75) by ($0.07). During the same quarter in the previous year, the company posted ($0.53) earnings per share.May 8, 2025 | marketbeat.comVoya Investment Management LLC Sells 281,664 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Voya Investment Management LLC decreased its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 84.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 52,313 shares of the company's stock afterMay 8, 2025 | marketbeat.comIDEAYA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business ...May 6, 2025 | gurufocus.comIDEAYA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 6, 2025 | gurufocus.comAvidity Partners Management LP Sells 246,300 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Avidity Partners Management LP decreased its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 17.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,126,700 shares of the company's stock after sellingMay 6, 2025 | marketbeat.comIDEAYA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 6, 2025 | prnewswire.comIDEAYA Biosciences Announces US FDA IND-Clearance for IDE849, a Potential First-in-Class DLL3 TOP1 ADC, for a Phase 1 Study in Solid TumorsMay 6, 2025 | prnewswire.comHsbc Holdings PLC Raises Stock Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Hsbc Holdings PLC raised its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 66.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 38,690 shares of the company's stock after buying an adMay 6, 2025 | marketbeat.comInvesco Ltd. Has $1.46 Million Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Invesco Ltd. cut its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 63.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 56,691 shares of the company's stock after sellinMay 3, 2025 | marketbeat.comTower Research Capital LLC TRC Has $495,000 Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Tower Research Capital LLC TRC raised its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 338.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 19,242 shares of tMay 2, 2025 | marketbeat.comIDEAYA Biosciences (IDYA) Projected to Post Quarterly Earnings on TuesdayIDEAYA Biosciences (NASDAQ:IDYA) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-ideaya-biosciences-inc-stock/)May 1, 2025 | marketbeat.comAquatic Capital Management LLC Buys 29,189 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Aquatic Capital Management LLC lifted its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 47.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 91,189 shares of the coMay 1, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Lowers Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Price T Rowe Associates Inc. MD decreased its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 3.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 3,866,908 shares of the company's stock after selling 148,390 shares during tApril 30, 2025 | marketbeat.comBarclays PLC Boosts Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Barclays PLC lifted its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 9.7% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 198,756 shares of the company's stock after buying an additional 17,586 sApril 29, 2025 | marketbeat.comIDEAYA Biosciences to Participate in Upcoming May 2025 Investor Relations EventsApril 28, 2025 | prnewswire.comAdage Capital Partners GP L.L.C. Has $30.84 Million Stock Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Adage Capital Partners GP L.L.C. boosted its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 22.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,200,094 shares of tApril 28, 2025 | marketbeat.comIDEAYA Biosciences Grants Stock Options To New Employees Under 2023 Inducement PlanApril 27, 2025 | nasdaq.comGuggenheim Capital LLC Takes Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Guggenheim Capital LLC acquired a new stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 31,389 shares of the companApril 26, 2025 | marketbeat.comIDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)April 25, 2025 | prnewswire.comMarshall Wace LLP Buys 60,361 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Marshall Wace LLP raised its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 23.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 312,666 shares of the company's stock after acquiringApril 25, 2025 | marketbeat.com Get IDEAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter. Email Address IDYA Media Mentions By Week IDYA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IDYA News Sentiment▼1.400.87▲Average Medical News Sentiment IDYA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IDYA Articles This Week▼96▲IDYA Articles Average Week Get IDEAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Blueprint Medicines News BridgeBio Pharma News Elanco Animal Health News Verona Pharma News Telix Pharmaceuticals Limited American Depositary Shares News Grifols News TG Therapeutics News Legend Biotech News Nuvalent News Axsome Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IDYA) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IDYA Stock Free IDYA Stock Alerts